ArticleThoracic cancer2022

Real-world experience of consolidation durvalumab after concurrent chemoradiotherapy in stage III non-small cell lung cancer.

Yiqing Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.